Policymakers must prioritize immunocompromised dialysis patients by allowing providers to allocate, distribute therapies
May 6, 2022
We’ve reached the unimaginable two-year milestone of the COVID-19 pandemic.
As we reflect on the last few years, we remember the incalculable loss and devastation endured by so many around the world, across the country, and in our own communities. Our daily lives and those of our patients were upended and shadowed with tremendous fear and uncertainty about the realities of living through a global pandemic.
While navigating through these years of unforeseen events, the kidney community came together and pivoted to a multi-pronged effort to continue providing life saving dialysis to those with severe kidney disease, while grappling with a virus we knew little about. The COVID-19 pandemic united our community and shed light on important policy changes that need to be addressed to protect our patients and providers against future crises that we may face.